Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories Gets CE Mark for SARS-CoV-2, Influenza RT-PCR Assay Kit

NEW YORK – Bio-Rad Laboratories has obtained CE-IVD marking for an assay kit to simultaneously detect SARS-CoV-2 and influenza viruses in a single reaction. The kit is now launched into European markets, the firm announced Wednesday.

The Reliance SARS-CoV-2/FluA/FluB RT-PCR Kit is a respiratory panel designed for clinical labs conducting COVID-19 testing, Bio-Rad said in a statement.

The test detects the N gene of SARS-CoV-2, the M1 gene of influenza A, and the NS2 gene of influenza B in nasopharyngeal swabs from individuals suspected of COVID-19 infection. It contains Bio-Rad's standards and negative controls and assay reagents and is validated to run on the firm's CFX96 DX Real-Time PCR system as well as real-time PCR systems from other manufacturers.

"With the upcoming flu season, a continuing COVID-19 pandemic, and many countries opening up and returning to the workplace, clinicians need a sensitive, reliable, and convenient way to detect common respiratory viruses and to differentiate cases of COVID-19 infection that do not involve flu A or flu B infection," said Steven Blakely, Bio-Rad's global director of marketing for the gene expression division of the life science group.

Bio-Rad noted that in silico analysis in March demonstrated that the assay is not affected by known variants with mutations in the spike protein-encoding gene.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.